Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 6 Results

Intervention Indication Therapeutic Area Year Actions
Budesonide-glycopyrronium-formoterol fumarate for the treatment of severe and inadequately controlled asthma Budesonide-glycopyrronium-formoterol fumarate Asthma Respiratory System 2024 View  |  Download
Depemokimab as adjunctive therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and older Depemokimab Asthma Respiratory System 2024 View  |  Download
Dupilumab in addition to controller medications for children aged 6 to 11 years with asthma controller medications , Dupilumab (Dupixent; REGN-668; SAR-231893; REGN668; SAR231893) Asthma Respiratory System 2021 View  |  Download
Fevipiprant maintenance therapy for uncontrolled asthma – add on therapy Fevipiprant (QAW-039) Asthma Respiratory System 2019 View  |  Download
Tezepelumab for severe, uncontrolled asthma Tezepelumab (AMG 157; MEDI9929) Asthma Respiratory System 2020 View  |  Download
Tralokinumab for severe, uncontrolled asthma Tralokinumab (CAT-354; LP 0162) Asthma Respiratory System 2017 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications